AMPLATZER PFO Occluder Post Approval Study
ClinicalTrials.gov NCT03309332
Research payments
$927,933
Through program year 2019, $927,933 in research payments was reported against AMPLATZER PFO Occluder Post Approval Study, across 417 payments, paid by Abbott Laboratories.
- Paid by
- Abbott Laboratories
- ClinicalTrials.gov
- NCT03309332
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $927,933 | 417 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mark Kozak Hershey, PA Named on 18 payments
- Wilson Ginete Duluth, MN Named on 14 payments
- Thomas Forbes Detroit, MI Named on 12 payments
- Konstantinos Boudoulas Columbus, OH Named on 8 payments
- David Lasorda Pittsburgh, PA Named on 8 payments
- Matthew Stahlman Austin, TX Named on 8 payments
- David Thaler Boston, MA Named on 7 payments
- Karen Orjuela Traslavina Aurora, CO Named on 7 payments
- Samuel Turner Winston Salem, NC Named on 7 payments
- Oluseun Alli Charlotte, NC Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.